Bristol-Myers Squibb Company:企業の戦略・SWOT・財務情報

◆英語タイトル:Bristol-Myers Squibb Company - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4431
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:69
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Bristol-Myers Squibb Company – Strategy, SWOT and Corporate Finance Report
Summary

Bristol-Myers Squibb Company – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Bristol-Myers Squibb Company (BMS or ‘the company’) is a global biopharmaceutical company. The company is involved in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines in various therapeutic areas that primarily include cardiovascular; virology, oncology, and immunoscience. The company’s major brands include Baraclude, Sustiva, Reyataz, Opdivo, Eliquis, Orencia, Sprycel, Yervoy and Empliciti. The company operates across the Americas, Europe, Asia, Australia, and other regions of the world. BMS is headquartered in New York City, New York.

Scope

- Detailed information on Bristol-Myers Squibb Company required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Bristol-Myers Squibb Company in the form of a SWOT analysis
- An in-depth view of the business model of Bristol-Myers Squibb Company including a breakdown and examination of key business segments
- Intelligence on Bristol-Myers Squibb Company’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Bristol-Myers Squibb Company, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Bristol-Myers Squibb Company and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Bristol-Myers Squibb Company as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Bristol-Myers Squibb Company’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Bristol-Myers Squibb Company: Company Overview 9
Bristol-Myers Squibb Company: Overview and Key Facts 9
Bristol-Myers Squibb Company: Overview 9
Bristol-Myers Squibb Company: Key Facts 9
Bristol-Myers Squibb Company: Key Employees 11
Bristol-Myers Squibb Company: Key Employee Biographies 13
Bristol-Myers Squibb Company: Major Products and Services 19
Bristol-Myers Squibb Company: Company History 20
Bristol-Myers Squibb Company: Management Statement 32
Bristol-Myers Squibb Company: Locations and Subsidiaries 35
Bristol-Myers Squibb Company: Key Competitors 36
Bristol-Myers Squibb Company: Company Analysis 37
Bristol-Myers Squibb Company: Business Description 37
Bristol-Myers Squibb Company: SWOT Analysis 39
Bristol-Myers Squibb Company: SWOT Overview 39
Bristol-Myers Squibb Company: Strengths 39
Bristol-Myers Squibb Company: Weaknesses 40
Bristol-Myers Squibb Company: Opportunities 41
Bristol-Myers Squibb Company: Threats 42
Bristol-Myers Squibb Company: Corporate Financial Deals Activity 44
Bristol-Myers Squibb Company: Financial Deals Overview 44
Bristol-Myers Squibb Company: Targets and Partners 46
Bristol-Myers Squibb Company: Top Deals 2014 – 2018YTD* 51
Bristol-Myers Squibb Company: Advisors 52
Bristol-Myers Squibb Company: Top Legal Advisors 52
Bristol-Myers Squibb Company: Mergers and Acquisitions 53
Bristol-Myers Squibb Company: Corporate Venturing 54
Bristol-Myers Squibb Company: Partnership 55
Bristol-Myers Squibb Company: Divestments 56
Bristol-Myers Squibb Company: Recent Developments 57
Bristol-Myers Squibb Company: News and Events Summary 57
Bristol-Myers Squibb Company: Contracts 61
Bristol-Myers Squibb Company: Corporate Governance 62
Bristol-Myers Squibb Company: Financial Deals 63
Bristol-Myers Squibb Company: Financial Performance 63
Bristol-Myers Squibb Company: Grants 63
Bristol-Myers Squibb Company: Market Developments 64
Bristol-Myers Squibb Company: Regulatory and Legal Events 65
Bristol-Myers Squibb Company: Research & Development 66
Appendix 67
Contact Us 67
Methodology 67
About MarketLine 68

List of Tables
Table 1: Bristol-Myers Squibb Company: Key Facts
Table 2: Bristol-Myers Squibb Company: Key Employees
Table 3: Bristol-Myers Squibb Company: Locations and Subsidiaries
Table 4: Bristol-Myers Squibb Company: Key Competitors
Table 5: Bristol-Myers Squibb Company: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Bristol-Myers Squibb Company: M&A Activity by Geography (TTM*)
Table 7: Bristol-Myers Squibb Company: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Bristol-Myers Squibb Company: M&A Average Deal Size - Value (US$m)
Table 9: Bristol-Myers Squibb Company: Targets and Partners
Table 10: Bristol-Myers Squibb Company: Top Deals 2014 - 2018YTD*
Table 11: Bristol-Myers Squibb Company: Legal Advisor Ranking by Value (US$m)
Table 12: Bristol-Myers Squibb Company: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Bristol-Myers Squibb Company: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Bristol-Myers Squibb Company: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 15: Bristol-Myers Squibb Company: Corporate Venturing by Geography (2014 - YTD*2018)
Table 16: Bristol-Myers Squibb Company: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 17: Bristol-Myers Squibb Company: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 18: Bristol-Myers Squibb Company: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 19: Bristol-Myers Squibb Company: News and Events Summary
Table 20: Bristol-Myers Squibb Company: Contracts
Table 21: Bristol-Myers Squibb Company: Corporate Governance
Table 22: Bristol-Myers Squibb Company: Financial Deals
Table 23: Bristol-Myers Squibb Company: Financial Performance
Table 24: Bristol-Myers Squibb Company: Grants
Table 25: Bristol-Myers Squibb Company: Market Developments
Table 26: Bristol-Myers Squibb Company: Regulatory and Legal Events
Table 27: Bristol-Myers Squibb Company: Research & Development

List of Figures
Figure 1: Bristol-Myers Squibb Company: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Bristol-Myers Squibb Company: M&A Activity by Geography (TTM*)
Figure 3: Bristol-Myers Squibb Company: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Bristol-Myers Squibb Company: M&A Average Deal Size - Value (US$m)
Figure 5: Bristol-Myers Squibb Company: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Bristol-Myers Squibb Company: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Bristol-Myers Squibb Company: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Bristol-Myers Squibb Company: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Bristol-Myers Squibb Company: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 10: Bristol-Myers Squibb Company: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 11: Bristol-Myers Squibb Company: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Bristol-Myers Squibb Company:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SAES Getters S.p.A. (SG):企業の財務・戦略的SWOT分析
    SAES Getters S.p.A. (SG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Epic Pharma LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Epic Pharma LLC (Epic Pharma), a subsidiary of Humanwell Healthcare (Group) Co Ltd is a drug development company that manufactures and develops generic prescription drugs. The company’s products include amlodipine besylate, citalopram, betaxolol, nicardipine hydrochloride, guanfacine hydroch …
  • Spectrum Pharmaceuticals Inc (SPPI):企業の財務・戦略的SWOT分析
    Spectrum Pharmaceuticals Inc (SPPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Renco Group SpA:企業の戦略的SWOT分析
    Renco Group SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Ultra Petroleum Corp. (UPL)-石油・ガス分野:企業M&A・提携分析
    Summary Ultra Petroleum Corp. (Ultra) is an independent upstream company which develops, produces, operates, explores, and acquires oil and natural gas properties. It develops its long-life natural gas reserves in the Green River Basin of Wyoming, the Pinedale and Jonah fields, and Appalachian Basin …
  • Sirenas LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Sirenas LLC (Sirenas), formerly Sirenas Marine Discovery LLC, is a biotechnology company that discovers therapeutics derived from nature's chemistry. The company’s proprietary data mining technologyATLANTIS uses data mining and machine learningapproach to uncover the therapeutic potential of …
  • Tecrea Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Tecrea Ltd (Tecrea) is a cell and tissue delivery technology for research and drug development applications. The company develops Nanocin reagents and ingredients support research and development in academic and industrial research labs. It develops Nanocin-plasmid and Nanocin-RNA kits that …
  • National Gas & Industrial Co (2080):企業の財務・戦略的SWOT分析
    National Gas & Industrial Co (2080) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Genmab AS (GEN):企業の財務・戦略的SWOT分析
    Genmab AS (GEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Biogen Inc (BIIB):企業の財務・戦略的SWOT分析
    Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • G4S plc:企業のM&A・事業提携・投資動向
    G4S plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's G4S plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • MedNet Solutions Inc-医療機器分野:企業M&A・提携分析
    Summary MedNet Solutions Inc (MedNet Solutions) is a healthcare technology company which provides eClinical and electronic data capture software solutions. The company developed iMedNet, an eClinical technology platform which provides non – technical clinical research for clinical trials or studies. …
  • Sekisui House Ltd (1928):企業の財務・戦略的SWOT分析
    Sekisui House Ltd (1928) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Rad Source Technologies Inc:企業の戦略的SWOT分析
    Rad Source Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Orion Corp (ORNBV):製薬・医療:M&Aディール及び事業提携情報
    Summary Orion Corp (Orion) is a developer of pharmaceuticals and diagnostic tests. The company develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients (APIs) and diagnostic tests. It focuses on developing pharmaceutical products for central nervous …
  • McKinsey & Co Inc:企業の戦略的SWOT分析
    McKinsey & Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Population Genetics Technologies Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Population Genetics Technologies Ltd (Population Genetics), a subsidiary of Agilent Technologies Inc is a biotechnology company. The company commercialize nucleic acid biochemistry tools and approaches. Its intellectual property assets include method for normalizing a nucleic acid sample, me …
  • Hatch Ltd:企業の戦略的SWOT分析
    Hatch Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Ivy Cosmetics Corporation:企業の戦略・SWOT・財務分析
    Ivy Cosmetics Corporation - Strategy, SWOT and Corporate Finance Report Summary Ivy Cosmetics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Seair Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Seair Inc, doing business as Dover Water Solutions, is a clean technology company that carries out research and development, production and sale of gas diffusion technologies. It focuses on commercializing advanced waste water and industrial fluid treatment solutions. The company offers high …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆